Publications

5901 Results

Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups

Authors
Hoffmann TJ;Graff RE;Madduri RK;Rodriguez AA;Cario CL;Feng K;Jiang Y;Wang A;Klein RJ;Pierce BL;Eggener S;Tong L;Blot W;Long J;Goss LB;Darst BF;Rebbeck T;Lachance J;Andrews C;Adebiyi AO;Adusei B;Aisuodionoe-Shadrach OI;Fernandez PW;Jalloh M;Janivara R;Chen WC;Mensah JE;Agalliu I;Berndt SI;Shelley JP;Schaffer K;Machiela MJ;Freedman ND;Huang WY;Li SA;Goodman PJ;Till C;Thompson I;Lilja H;Ranatunga DK;Presti J;Van Den Eeden SK;Chanock SJ;Mosley JD;Conti DV;Haiman CA;Justice AC;Kachuri L;Witte JS
Journal / Conference
Nat Genet. 2025 Feb;57(2):334-344. doi: 10.1038/s41588-024-02068-z. Epub 2025 Feb 10.
Year
2025
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID39930085
PMC
PMC11821537
Study Number(s)
S0000, SWOG-9217

Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate Cancer

Authors
Hunt TC;Malshy K;Steidle M;Li A;Fairbourn J;Cheng Z;Bandari J
Journal / Conference
Prostate. 2025 Dec;85(16):1522-1530. doi: 10.1002/pros.70043. Epub 2025 Sep 9.
Year
2025
Research Committee(s)
Genitourinary
PMID
PMID40926427
Study Number(s)
CTSU/C90203, S9921

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Authors
Janni W;Friedl TWP;Yab TC;Bidard FC;Cristofanilli M;Hayes DF;Ignatiadis M;Regan MM;Alix-Panabieres C;Barlow WE;Caldas C;Carey LA;Dirix L;Fehm T;Garcia-Saenz JA;Gazzaniga P;Generali D;Gerratana L;Gisbert-Criado R;Jacot W;Jiang Z;Joosse SA;Lianidou E;López López R;Magbanua MJM;Manso L;Mavroudis D;Müller V;Munzone E;Pantel K;Pierga JY;Rack B;Riethdorf S;Rugo HS;Sideras K;Sleijfer S;Smerage J;Stebbing J;Terstappen LWMM;Vidal-Martínez J;Wallwiener M;Giridhar KV;Liu MC
Journal / Conference
Clin Cancer Res. 2025 Jun 3;31(11):2196-2209. doi: 10.1158/1078-0432.CCR-24-3108
Year
2025
Research Committee(s)
Breast
PMID
PMID40100138
PMC
PMC12130808
Study Number(s)
S0500

Novel clinical trial designs emerging from the molecular reclassification of cancer

Authors
Nikanjam M;Kato S;Allen T;Sicklick JK;Kurzrock R
Journal / Conference
CA Cancer J Clin. 2025 May-Jun;75(3):243-267. doi: 10.3322/caac.21880. Epub 2025 Jan 22.NIHMS2049643
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39841128
PMC
PMC12061631
Study Number(s)
S1609

Assessing Health Information Seeking Behaviors Among Targeted Social Media Users Using an Infotainment Video About a Cancer Clinical Trial: Population-Based Descriptive Study

Authors
Sommers J;Dizon DS;Lewis MA;Stone E;Andreoli R;Henderson V
Journal / Conference
JMIR Cancer. 2025 Mar 3;11:e56098. doi: 10.2196/56098
Year
2025
Research Committee(s)
Palliative Care
PMID
PMID40029972
PMC
PMC11892945
Study Number(s)
S1501

ASO Author Reflections: Reasonable Doubt: The Case for Somatostatin Analogs in Pancreas Surgery Remains Unsettled

Authors
Goodsell KE;Sham JG
Journal / Conference
Ann Surg Oncol. 2025 Oct;32(10):7459-7460. doi: 10.1245/s10434-025-17730-x. Epub 2025 Jun 23.
Year
2025
Research Committee(s)
Palliative Care
PMID
PMID40549085
Study Number(s)
S2408

If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide

Authors
Adashek JJ;Munoz JL;Kurzrock R
Journal / Conference
Med. 2025 Jan 10;6(1):100550. doi: 10.1016/j.medj.2024.11.003. Epub 2024 Dec 16.NIHMS2033552
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39689708
PMC
PMC11725447

Tumour-agnostic kinase inhibitors

Authors
Adashek JJ;Nikanjam M;Kurzrock R
Journal / Conference
Nat Rev Drug Discov. 2025 Jul;24(7):504-520. doi: 10.1038/s41573-025-01147-y. Epub 2025 Mar 6.NIHMS2077643
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40050521
PMC
PMC12221794

Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly

Authors
Adashek JJ;Moran JA;Le DT;Kurzrock R
Journal / Conference
Cancer Metastasis Rev. 2025 Apr 4;44(2):43. doi: 10.1007/s10555-025-10260-8
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40183852
PMC
PMC11971148

Screening and Referral for Health-Related Social Needs and Financial Distress: Current Processes Among National Cancer Institute Community Oncology Research Program Practices

Authors
Banegas MP;Nightingale CL;Dressler EV;Cooley ME;Kamen C;Wagner LI;Kittel CA;Flores EJ;Carlos R;Milton A;Park E;Parsons SK;Wood EG;Loh KP;Ramsey S
Journal / Conference
JCO Oncol Pract. 2025 Oct;21(10):1512-1521. doi: 10.1200/OP-24-00902. Epub 2025 Mar 13.NIHMS2055153
Year
2025
Research Committee(s)
Cancer Care Delivery
PMID
PMID40080774
PMC
PMC12347083